RT Journal Article
SR Electronic
T1 KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006530
DO 10.1136/jitc-2022-006530
VO 11
IS 2
A1 Erbe, Amy K
A1 Diccianni, Mitch B
A1 Mody, Rajen
A1 Naranjo, Arlene
A1 Zhang, Fan F
A1 Birstler, Jen
A1 Kim, KyungMann
A1 Feils, Arika S
A1 Hung, Jung-Tung
A1 London, Wendy B
A1 Shulkin, Barry L
A1 Mathew, Varsha
A1 Parisi, Marguerite T
A1 Servaes, Sabah
A1 Asgharzadeh, Shahab
A1 Maris, John M
A1 Park, Julie
A1 Yu, Alice L
A1 Sondel, Paul M
A1 Bagatell, Rochelle
YR 2023
UL http://jitc.bmj.com/content/11/2/e006530.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.